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or the entire peritoneal cavity during the procedure. Peritoneal wash-
ing was performed for cytologic analysis. A left salpingectomy was
performed and removed with an endobag.
Histopathologic examination revealed a tumor of 2 cm in diameter
with complete inﬁltration and rupture of the fallopian tubewall. The peri-
tonealwashingwas positive. The neoplasmwas composed of a dense and
monomorphic population of small undifferentiated cells (Fig. 2), with
high mitotic activity (Ki 67: 80%). Immunostaining showed that the
tumor was neuroendocrine, as it was positive for pan-cytokeratin AE1–(8G7G3/1).Introduction
Neuroendocrine carcinomas (NECs) originate from endocrine cells
of the diffuse neuroendocrine system, arising mainly in the gastroin-
testinal tract, lungs, and pancreas (Pinchot et al., 2008). They are rare-
ly seen in the female genital system, and when they are, they are
found most commonly in the ovaries and cervix (Eichhorn and
Young, 2001). Very exceptionally, NEC occurs in another part of the
genital tract (e.g., the endometrium or vagina), where it can present
the pathologist with a diagnostic dilemma and the gynecologist
with a therapeutic challenge. Only two previous cases of primary
NEC in the fallopian tube have been reported to date (Neumann et
al., 2010; Dursun et al., 2004). Here we present a new case and dis-
cuss its unique clinical presentation, pathological ﬁndings, and thera-
peutic management.
Case report
A 59-year-old postmenopausal woman was admitted through the
emergency department for acute pelvic pain. Her medical history was
unremarkable. She had one uncomplicated vaginal delivery.
She presented with an intense pelvic pain, and medical examina-
tion showed no other symptoms. Ultrasound and computed tomogra-
phy (CT) examinations showed a highly dense left adnexal mass of
7 cm in diameter (Fig. 1). During the exploratory laparoscopy, we ob-
served a torsion with necrosis at the distal part of the left fallopian(P. Crochet).
-ND license.AE3 (polyclonal), chromogranin A (clone DAK-A3), synaptophysin
(clone SY38), neuron-speciﬁc enolase (BBS/NcV1-H14) and CD56 (1B6)
(Fig. 3). Tumor cells also exhibited nuclear immunoreactivity with TTF1
An additional laparotomy was performed 3 weeks later: staging,
total hysterectomy, right salpingo-oophorectomy, left oophorectomy,
omentectomy and pelvic and para-aortic lymphadenectomy. ThereFig. 1. Emergency Pelvic CT scan (left adnexal mass).
Fig. 2. Dense monomorphic population of small undifferentiated cells. Fig. 3. Homogeneous positive immunostaining for CD 56.
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during the procedure. The pathology examination found multiple
neoplastic foci located in the right adnexa and omentum. Metastasis
was found in two out of the 44 lymph nodes removed. These two
metastatic nodes were located in the para-aortic area.
Imaging performed before the laparotomy (abdominal and tho-
racic CT and PET-FDG) and postoperatively (bone scintigraphy, spinal
MRI) found no distant metastasis.
Adjuvant chemotherapy was then administered. The patient toler-
ated 6 cycles of carboplatin/etoposide well and is alive 9 months after
the initial diagnosis, with no evidence of recurrence or relapse.Comment
NECs originate fromendocrine cells of the diffuse neuroendocrine sys-
tem, which in turn consists of a variety of cells present in the central and
peripheral nervous systems and in several endocrine organs. These cells
can produce many biologically active amines and peptides able to act as
neurotransmitters, hormones, or paracrine regulators. Neuroendocrine
cells have been identiﬁed within normal epithelium throughout the fe-
male genital tract by a number of techniques (Eichhorn and Young,
2001), but their presence in the fallopian tube has not been clearly
demonstrated. Some authors suggest that NECs of the female geni-
tal tract arise from mullerian epithelial stem cells in the uterus
(Sivridis et al., 1989). Other potential sources of NEC in the female
genital tract include migrational errors of neuroendocrine cells,
their implantation during previous surgery, neuroendocrine differ-
entiation of uncommitted stromal cells, or metastasis (Neumann et
al., 2010).
The clinical presentation of this case is unique, since the symptoms
suggested adnexal torsion rather than the fairly improbable ruptured
salpingian tumor that was found. The dense adnexal mass revealed by
the CT scan did not indicate the unusual nature of this tumor. Pelvic
pain was the main symptom in the previous cases reported, but its
onset was progressive, and the clinical examination revealed a palpable
adnexal mass. Surgical resectionwas achievedwith negative microscop-
ic margins in both cases (Neumann et al., 2010; Dursun et al., 2004).
Most NECs of the female genital tract are small-cell carcinoma, as
here. Neumann et al., however, reported a case of primary NEC of the
fallopian tube composed of medium to large cells (Neumann et al.,
2010). Fallopian tube NECs appear to be aggressive neoplasms, like
other NEC in the gynecologic tract. High mitotic activity was similarly
described in the two previous case reports (Neumann et al., 2010;
Dursun et al., 2004).NEC diagnosis requires immunohistochemical analysis. The most
commonly used nonhormonal immunohistochemical markers are
chromogranin A, synaptophysin, cytokeratin, and CD56. NSE and
Leu-7 lack speciﬁcity and may not be conclusive for neuroendocrine
differentiation when other stains are negative (Eichhorn and Young,
2001). In our case, the immunostaining was consistent with the histo-
pathologic examination and conﬁrmed the neuroendocrine nature of
the tumor. Immunostaining for amine (serotonin) and peptide (so-
matostatin, glucagon, calcitonin, vasoactive intestinal peptide) hor-
monal markers was negative, consistent with the patient's lack of
endocrine symptoms.
The TTF1 immunoreactivity observed raises the issue of the origin of
the neoplasm. This marker is a widely used and useful immunohisto-
chemical marker of thyroid and pulmonary neoplasms, including pri-
mary pulmonary adenocarcinomas and small-cell carcinomas (Travis,
2010). However, TTF1 positivity is extremely common and may be a
useful marker of primary neuroendocrine carcinomas of other organs
as well. It is of no value in ruling out a primary pulmonary NEC, and
cases of NECs from the female genital tract positive for TTF1 have
been reported (McCluggage et al., 2010). In this case, the absence of pul-
monary symptoms and the normal thoracic images further points in
favor of a primary fallopian tube NEC. Our thorough search of the liter-
ature indicates that this is only the third primary monomorphic NEC of
the fallopian tube to be reported. Two other cases of mixed tumors of
the fallopian tube with either a mullerian tumor or a teratoma associat-
ed with a NEC have been described (Astall et al., 2000).
Because these tumors are so rare, their optimal treatment has not
been established. Combination therapy might be useful because of
their usually aggressive course. The most logical approach might be
surgical treatment similar to that of other fallopian tube carcinomas,
followed by an adjuvant chemotherapy protocol as proposed for neu-
roendocrine tumors. In our case, poor prognosis factors included the
preoperative ruptured tumor, the high mitotic activity and metastatic
implants found in the right adnexa, omentum and para-aortic nodes.
In conclusion, primary fallopian tube neuroendocrine carcinoma is
very rarewith our case only the third to be reported. Its diagnosis requires
simultaneous consideration of the pathological, immunohistochemical
and radiological ﬁndings and discarding differential diagnoses. Treatment
is not standardized. However the use of chemotherapy commonly used
for treating NEC (carboplatin/etoposide) appears to be a reasonable op-
tion. The prognosis of NEC tumor is poor though our patient iswithout ev-
idence of disease after 9 months.
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